Global Med Sa Stock EBITDA
| 9PU Stock | EUR 1.12 0.01 0.90% |
GLOBAL MED SA fundamentals help investors to digest information that contributes to GLOBAL COSMED's financial success or failures. It also enables traders to predict the movement of GLOBAL Stock. The fundamental analysis module provides a way to measure GLOBAL COSMED's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to GLOBAL COSMED stock.
GLOBAL |
GLOBAL MED SA Company EBITDA Analysis
GLOBAL COSMED's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, GLOBAL MED SA reported earnings before interest,tax, depreciation and amortization of 0.0. This is 100.0% lower than that of the Consumer Defensive sector and 100.0% lower than that of the Household & Personal Products industry. The ebitda for all Germany stocks is 100.0% higher than that of the company.
GLOBAL EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses GLOBAL COSMED's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of GLOBAL COSMED could also be used in its relative valuation, which is a method of valuing GLOBAL COSMED by comparing valuation metrics of similar companies.GLOBAL MED is currently under evaluation in ebitda category among its peers.
GLOBAL Fundamentals
| Return On Equity | 0.0183 | |||
| Return On Asset | 0.0111 | |||
| Profit Margin | 0.01 % | |||
| Shares Outstanding | 87.1 M | |||
| Shares Owned By Insiders | 88.20 % | |||
| Gross Profit | 117.36 M | |||
| Debt To Equity | 0.28 % | |||
| Current Ratio | 0.95 X | |||
| Earnings Per Share | 0.01 X | |||
| Number Of Employees | 589 | |||
| Beta | 2.47 | |||
| Market Capitalization | 40.02 M | |||
| Annual Yield | 0.01 % |
About GLOBAL COSMED Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze GLOBAL MED SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GLOBAL COSMED using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GLOBAL MED SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in GLOBAL Stock
GLOBAL COSMED financial ratios help investors to determine whether GLOBAL Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GLOBAL with respect to the benefits of owning GLOBAL COSMED security.